Skip to main content

$1.17 (0.00%)

High

$1.20

Low

$1.17

Trades

19

Turnover

$42,881

Volume

36,527
30 June 2023 at 4:10pm
Register to track EMV and receive email alerts.

Clinical Trial Data Drives Confidence for Expanded Studies

StockBot

416,823 posts

EMV released this announcement to the ASX on 30 November 2021, 9:10. The announcement is marked as price sensitive, and is 5 page(s) in length and 254.43kb in size.

You can view all announcements from EMV and see how they appear on a price chart on the announcements page.

At the date of this announcement, EMV was 0.009% short sold according to ASIC data. It was ranked the 623rd most shorted stock on the ASX. It is now ranked as the 347th most shorted stock on the ASX with 0.312% of total shares short sold as of the latest reported data (15 April 2025).

Other Recent Announcements from EMV
Recruitment at Royal Melbourne Hospital Commences 29 June 2023, 8:20
$1.75M Manufacturing Grant Payment Received 13 June 2023, 9:05
Leadership Transition 31 May 2023, 9:00
Clinical Trial Data Drives Confidence for Expanded Studies 30 November 2021, 9:10
Results of Annual General Meeting 25 November 2021, 14:26
AGM Chairman's Address & Presentation 25 November 2021, 13:34
Advance QLD Industry Fellowship Win 24 November 2021, 8:15
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track EMV and receive email alerts.